SC 13G/A: PAINREFORM LTD.

AI Summary

SC 13G/A filing by PAINREFORM LTD..

Risk Assessment

Risk Level: low

FAQ

Filing Documents

• zk2431000.htm (SC 13G/A) — 328KB
• 0001178913-24-000622.txt ( ) — 329KB

(a)

Item 1(a). Name of Issuer: The name of the issuer is PainReform Ltd.

(b). Address of Issuer's Principal Executive Offices

Item 1(b). Address of Issuer's Principal Executive Offices: The Issuer's principal executive offices are located at 60C Medinat Hayehudim, Herzliya, 4676652, Israel.

(a)

Item 2(a). Name of Person Filing: The following entity and individuals, listed in (i)-(viii) below, who are filing this Statement of Beneficial Ownership on Schedule 13G (this " Statement "), are referred to herein collectively as the " Reporting Persons ": General Partners : Medica III Management Co., a Cayman Islands corporation Medica III Management L.P., a Cayman Islands limited partnership Investment Funds: Medica III Investments (International) L.P. a Cayman Islands limited Partnership Medica III Investments (Israel) L.P. an Israeli limited partnership Medica III Investments (S.F.) L.P. a Cayman Islands limited partnership Medica III Investments (P.F.) L.P. an Israeli limited partnership Medica III Investments (Israel) (B) L.P. an Israeli limited partnership Poalim Medica III Investments L.P. an Israeli limited partnership Officers/Directors: Ehud Geller, an Israeli citizen and an officer and director of Medica III Investment group. Batsheva Elran, an Israeli citizen and an officer and director of Medica III Investment group.

(b)

Item 2(b). Address of Principal Business Office or, if None, Residence: The principal business office of each Reporting Person is as follows: c/o Medica III Investment Group 60C Medinat Hayehudim Herzliya, 44676652, Israel

(c)

Item 2(c). Citizenship: Each of the entities or persons identified in Item 2(a) above is a corporation, limited partnership or individual organized under the laws of the jurisdiction, or is a citizen of the jurisdiction, as applicable, set forth opposite such entity's or person's name.

(d)

Item 2(d). Title of Class of Securities: Ordinary shares, par value NIS 0.30 per share.

(e)

Item 2(e). CUSIP Number: The CUSIP number of the Ordinary Shares is M77798128. Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Not applicable. Item 4. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. I. Medica III Management Co. is the general partner of Medica III Management L.P., the general partner of each of the investments funds named in Item 2(a) above: (a) Amount beneficially owned together with all other Reporting Persons: 346,478 Ordinary Shares (b) Percent of class*: 19.85% (c) Number of shares as to which the person together with all other Reporting Persons has: (i) Sole power to vote or to direct the vote: 346,478 (ii) Shared power to v

View Full Filing

View this SC 13G/A filing on SEC EDGAR